“…In particular, the sequence comparison of TgCyp23 with human CypA suggested that, among the 13 residues characterizing the CsA-binding pocket in the human CypA–CsA complex (Arg55, Phe60, Met61, Gln63, Gly72, Ala101, Asn102, Ala103, Gln111, Phe113, Trp121, Leu122, His126), 12 are identical in TgCyp23, including a single tryptophan that is likely to be critical for CsA binding. However, TgCyp23 possesses a 40-residue N-terminal extension relative to human CypA (Figure ) that might be involved in the membrane interaction and subcellular localization in agreement to other parasitic systems . On the other hand, TgCyp18.4 contains some striking amino acid substitutions in the active site (e.g., Met61, Trp121, and His126 of CypA are replaced by Ala50, His111, and Tyr116, respectively, in TgCyp18.4), which could, in principle, influence the catalytic properties of the enzyme and its affinity for CsA, making it an attractive candidate for the design of new CsA derivative compounds (Figure ).…”